Centessa Pharmaceuticals PLC ADR Financial Flexibility Index
Centessa Pharmaceuticals PLC ADR financial flexibility index. Centessa Pharmaceuticals PLC ADR (CNTA) has a Financial Flexibility Index of -0.47x as of March 2026. Free cash flow of $-72.22 Million (operating CF $-72.22 Million minus capex $0.00) represents 0% of total liabilities ($154.41 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Centessa Pharmaceuticals PLC ADR (2019–2025)
Financial flexibility index of Centessa Pharmaceuticals PLC ADR from 2019 to 2025. Historical Financial Flexibility Index trend for Centessa Pharmaceuticals PLC ADR across 7 annual periods. Explore cash flow to debt ratio of Centessa Pharmaceuticals PLC ADR to assess how comfortably operating cash covers total debt obligations.
Centessa Pharmaceuticals PLC ADR Financial Flexibility Index by Year (2019–2025)
Centessa Pharmaceuticals PLC ADR financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Centessa Pharmaceuticals PLC ADR. For the full cash flow conversion analysis, see CNTA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.20x | $-193.45 Million | $-193.82 Million | $160.63 Million | ▼ -48.6% |
| 2024 | -0.81x | $-142.02 Million | $-142.06 Million | $175.25 Million | ▲ +37.3% |
| 2023 | -1.29x | $-160.17 Million | $-160.34 Million | $124.00 Million | ▲ +30.0% |
| 2022 | -1.84x | $-199.41 Million | $-200.55 Million | $108.14 Million | ▼ -87.3% |
| 2021 | -0.98x | $-135.96 Million | $-136.14 Million | $138.08 Million | ▲ +18.7% |
| 2020 | -1.21x | $-10.44 Million | $-10.63 Million | $8.62 Million | ▼ -30.3% |
| 2019 | -0.93x | $-5.64 Million | $-5.83 Million | $6.07 Million | — |